Application progresses of drug-coated balloon for femoropopliteal disease
10.13929/j.1672-8475.201705012
- VernacularTitle:药物涂层球囊在股腘动脉硬化性病变中的应用进展
- Author:
Xujiao CHEN
- Keywords:
Lower extremity;
Arteriosclerosis obliterans;
Femoropopliteal artery;
Drug-coated balloon;
Restenosis
- From:
Chinese Journal of Interventional Imaging and Therapy
2017;14(9):576-579
- CountryChina
- Language:Chinese
-
Abstract:
Percutaneous transluminal angioplasty is the preferred treatment of femoropopliteal arterial disease at present.But the high rate of restenosis needs to be solved rapidly.As a new treatment strategy,drug-coated balloon (DCB) can reduce the late lumen lose and the revascularization of target lesion by inhibiting intimal proliferation and inflammatory response,also it can treat femoropopliteal in-stent restenosis effectively.In addition,combining DCB and atherectomy or stenting can improve the outcomes for severe stenosis of femoropopliteal artery.The recent application progresses of DCB for femoropopliteal disease were reviewed in this article.
